Thank you for the submission of your manuscript to EMBO reports and I am sorry for the small delay in getting back to you. Your manuscript was sent to four referees and we have now received the reports from three of them, which are copied below. Given that they are all in fair agreement that you should be given a chance to revise the study, I am making a decision on your manuscript now in order to safe you from any unnecessary loss of time.
Thank you for the submission of your manuscript to EMBO reports and I am sorry for the small delay in getting back to you. Your manuscript was sent to four referees and we have now received the reports from three of them, which are copied below. Given that they are all in fair agreement that you should be given a chance to revise the study, I am making a decision on your manuscript now in order to safe you from any unnecessary loss of time.
As you will see, while the referees acknowledge that the findings are potentially interesting, they also all point out that significant revisions are required before the study can be considered for publication by EMBO reports. The most important point raised by all three referees is that the effects of CCRK depletion on cilia growth are small. All referees point out that rescue experiments need to be performed. Two referees each further indicate that the cells need to be synchronized, that it needs to be addressed how the small effect on cilia growth can have such a large effect on cell cycle progression, that the effect of a phosphomimick mutant of ICK should be examined, that statistical analyses need to be performed for all relevant data, that localization of CCRK in cilia/cells should be investigated, and that the effect of CCRK on Hedgehog signaling could be further analyzed. Referee 3 also remarks that the PI3K data should be removed, and I agree that it would be better if the manuscript concentrated on the potential central finding that CCRK promotes cancer cell proliferation by inhibiting cilia formation.
Given these constructive referee comments, we would like to invite you to revise your manuscript with the understanding that the referee concerns must be fully addressed and their suggestions (as detailed above and in their reports) taken on board. Acceptance of the manuscript will depend on a positive outcome of a second round of review and I should also remind you that it is EMBO reports policy to allow a single round of revision only and that, therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
Revised manuscripts should be submitted within three months of a request for revision; they will otherwise be treated as new submissions. Also, the revised manuscript may not exceed 30,000 characters (including spaces and references) and 5 figures plus 5 supplementary figures, which should directly relate to their corresponding main figure. Please also specify the number (n) of experiments, the error bars and the statistical tests used to calculate p-values for all quantifications in the corresponding figure legends. This information is currently incomplete. Where possible, please show the average data of at least three independent experiments with error bars and statistical analyses. Please note that error bars cannot be calculated for 2 or less independent experiments (currently in Figure 1C , 3B).
When submitting your revised manuscript, please include:
A Microsoft Word file of the manuscript text, editable high resolution TIFF or EPS-formatted figure files, a separate PDF file of any Supplementary information (in its final format) and a letter detailing your responses to the referee comments.
We also recently decided to offer the authors the possibility to submit "source data" with their revised manuscript that will be published in a separate supplemental file online along with the accepted manuscript. If you would like to use this opportunity, please submit the source data (for example entire gels or blots, data points of graphs, additional images, etc.) of your key experiments together with the revised manuscript.
We would also welcome the submission of cover suggestions, or motifs to be used by our Graphics Illustrator in designing a cover.
As part of the EMBO publication's Transparent Editorial Process, EMBO reports publishes online a Review Process File to accompany accepted manuscripts. This File will be published in conjunction with your paper and will include the referee reports, your point-by-point response and all pertinent correspondence relating to the manuscript.
You are able to opt out of this by letting the editorial office know (emboreports@embo.org). If you do opt out, the Review Process File link will point to the following statement: "No Review Process File is available with this article, as the authors have chosen not to make the review process public in this case." I look forward to seeing a revised version of your manuscript when it is ready.
REFEREE REPORTS:
Referee #1:
The article entitled "Inhibition of ciliogenesis by CCRK and its effectors ICK and MAK promotes glioblastoma cell proliferation" by Yang and colleagues describes a series of experiments that analyse the consequences of CCRK depletion in cilliogenesis. CCRK is a cell cycle related kinase, almost unexplored and so this study provides novelty that can be of interest to the ciliogenesis and cell cycle fields. I consider that this article might be considered for publication by EMBO reports, after a major revision of several points that required clarification. I think the authors needs to include more cell cycle data to fully understand the effect on cell cycle progression and as a suggestion use a synchronised cell population for cell cycle studies. 1-On a general note, I was not able to find information about the number of cells analysed in every experiment. This is of course important to understand the relevance of the phenotype in NIH3t3 cells and in the glioblastoma cell line. In addition, I am also not sure whether the authors performed rescue experiments to validate the specificity of CCRK knock down. I known that knock down of CCRK orthologues in other species gives similar results, but nevertheless this type of experimental control is essential in knock down experiments. 2-In Figure 1 , the cilium size in CCRK depletion is double the control cilium size. On average length, this is much less evident (2.8 vs 2.3). Also the variation in axoneme leght seems enormous both in control and depletion. Can the authors comment on this? The use of synchronised cells would probably help. 3-The Hg signalling evaluation suggests to the authors increased Hg signalling activity. They mention, page 5, "in cells where cilia frequency was comparable to siNT cells. I do not understand the sentence or the way the experiment was done. Are the authors certain that both cell types are at the same cell cycle phase? Can they measure Hg signalling activity in CCRK depleted cells that present different cilia sizes? This should be a more direct readout of the influence of size upon ligand stimulation. 4-The authors state that CCRK is not enriched in basal bodies and cilia and give a reference. Did they confirm these results? The data given on reference 11 given does not really show unequivocally, the absence of CCRK in BB or cilia. This is particularly important in light of the localisation of ICK at the BB. 5-The authors show that Alanine substitution in the fusion GST-ICK-T157 does not affect its localisation, but has an effect on ciliogenesis. An alternative experiment should be performed. Can the authors phosphomimick phosphorylation in the same residue and see an effect in Control and CCRK depleted cells? 6-The interpretation of the data where Kif3A is depleted is somehow confusing. The authors state that CCRK or ICK knockdown did not increase cilia length in Kif3a depleted cells. In my interpretation this result shows quite directly that the effect on cilia size is IFT dependent. When measuring the % of cells with EDU incorporation, the authors state that CCRK and ICK promote cell cycle progression by inhibiting ciliogenesis. However, another interpretation, is that inhibition of cell cycle progression by CCRK/ICK takes place (requires a) at a functional cilium. In the experiment provided in Fig 3 and S3 , the authors have not synchronised their cell population ( if I understand their data correctly) and so, do not know at which stage of the cell cycle initially their cells are. 7-In the U251 cell line, does CCRK depletion also lead to a lengthening of the cilium in cells that can grow cilia. Also a cell cycle profile analysis done with Facs would probably help to characterise the cycling/non-cycling population in both NIH3t3 and U251 cells.
Referee #3:
Review of manuscript by Yang and coworkers (EMBOR-2012-36935V1) The authors report that the CCRK kinase and its substrate ICK negatively regulate the length of primary cilia, as well as Hedgehog signaling, in cultured mammalian cells. Moreover, by depleting the IFT motor Kif3a, which is essential for cilium formation, they show that the inhibitory effects of CCRK and of ICK on cell cycle progression depend on the presence of cilia. CCRK is known to be overexpressed in glioblastoma cells and to promote their proliferation, and the authors report here that CCRK knockdown restores cilium formation in a fraction of glioblastoma cells and also curbs their proliferation.
The interplay between primary cilia and proliferation control is of considerable interest, such that this study could be of potential interest for the EMBO Reports readership. However, additional experiments need to be conducted and many points clarified further to strengthen the manuscript sufficiently to consider publication in this Journal, as detailed below. In addition, the novelty of some of the findings is undermined by the fact that related observations were reported previously for CCRK and ICK proteins in other systems, as noted by the authors themselves in their manuscript.
Main issues 1) The difference in axoneme length reported in Fig. 1B , although statistically significant, is particularly small. It is difficult to imagine how a difference of approximately 20% in primary cilium length would have important functional consequences. Also, particularly when considering such a small difference, the authors must address whether this phenotype can be rescued by expressing a CCRK plasmid engineered to be resistant to siRNAs, or else by using the mouse clone to rescue the phenotype in human cells, or reciprocally.
2) Fig. 4 reports that CCRK depletion restores cilia in a fraction of U251MG glioblastoma cells and also that CCRK depletion has less of an impact on cells lacking cilia than on cells harboring them. Together, these results lead the authors to conclude that CCRK promotes glioblastoma cell proliferation by inhibiting cilia formation, a central novel claim of the manuscript. Two things need to be clarified before such a conclusion can be drawn with more certainty. Firstly, the authors need to show that the cell cycle status of cells treated with siNT and with siCCRK are similar. Indeed, it could be that the slight increase in cells with cilia (from 2% to 8% of cells) reflects the fact that more cells are in G0/G1 as a consequence of lacking CCRK, which would obviously lead to more ciliated cells in the population. Secondly, the authors need to explain how such a seemingly small impact on the fraction of ciliated cells can have such a major consequence on cell proliferation, as reported in Fig. 4E and Fig. 4F . These critical points must be clarified.
Other points 3) On page 4, the authors write that the role of CCRK in ciliary length control is "... consistent with previous work in Chlamydomonas...". In fact, the LF2 mutant phenotype in Chlamydomonas is quite distinct from the slightly longer axoneme phenotype reported here upon CCRK knockdown, with flagella being typically shorter and exhibiting an altered morphology in the LF2 mutant cells. Moreover, although this is not the focus of the study, an analysis of primary cilia upon depletion of CCRK with electron-microscopy would have been an interesting addition, also to further explore potential phenotypic similarities between organisms. 4) In several places (e.g. Fig. 1B, Fig. 3B, Fig. S2D ), the authors show the data from only one representative experiment, even though they have conducted several of them. The entire data set should be shown, which is especially important considering that the changes reported in some of these cases are rather small (e.g. in Fig. 1B for instance).
5) The authors switch from analyzing the length of primary cilia (as in Fig. 1B ) to analyzing the fraction of cells with cilia (as in Fig. 2 ). The two are not interchangeable and correspond to distinct cell biological processes that should be treated separately. 6) Statistical analysis should be performed for the data reported in Fig. S3 . 7) On page 4, the authors conclude from the data reported in Fig. 1C that "...CCRK knockdown increases cilia stability" and that "...CCRK is a negative regulator of ciliogenesis". These appear as overstatements in the light of the available data. Are the differences between siNT and siCCRK upon serum restimulation and reported in Fig. 1C statistically significant? This should be clarified.
8) The authors report the intriguing observation that there is an elevation of Hh pathway activity in cells depleted of CCRK, and imply that this correlates with the presence of longer cilia. This interesting suggestion could be addressed experimentally, for instance by testing whether the extent of the presence of Gli3 at ciliary tips correlates with ciliary length amongst cells depleted of CCRK. 9) At the end of page 5, the authors introduce MAK as the most logical CCRK substrate to investigate, but then chose to study ICK instead without ever coming back to MAK. This is somewhat unsettling.
10) The fact that CCRK knockdown does not alter ciliary frequency in GST-ICK-T157A expressing cells (Fig. 2B) leads the authors to conclude that ICK mediates the inhibitory function of CCRK. To strengthen this claim, the authors should consider testing whether a T157D/E mutant behaves like GST-ICK.
11) This may be perceived merely as a semantic distinction, but one that seems important: on page 8, the authors conclude that their experiments "... demonstrate that CCRK and ICK promote cell cycle progression by inhibiting ciliogenesis in NIH3T3 cells". It appears instead that these experiments merely demonstrate that cilia are needed for CCRK and ICK to positively regulate cell cycle progression. This is interesting, but does not necessarily mean that the inhibition of ciliogenesis is what promotes cell cycle progression upon CCRK overexpression; the two effects could be happening in parallel.
12) The findings reported in Fig. S4B implicating PI3K as a potential regulator of CCRK are of interest, but appear insufficiently developed for the time being to warrant inclusion in this manuscript, especially since the contribution of PI3K is only partial. 13) In the discussion, the authors claim to have identified a "novel mechanism of ciliogenesis inhibition" (page 10). This claim is no warranted because there is little mechanistic insight in this study about how CCRK/ICK negatively regulate this process, and also because the requirement of these proteins in ciliogenesis is far from "novel". 14) On page 11, the authors refer to Fig. 1D (which does not exist) instead of Fig 17) The wording in the Supplementary Methods section could use some polishing.
Referee #4:
The paper identifies a linear pathway in which PI3K signaling leads to the upregulation of CCRK, which in turn activates ICK/MAK kinases to suppress ciliary formation and promote cell cycle progression. This pathway is operational in the U251G gliobastoma cell line, which shows high level of expression of CCRK, and contributes to the proliferation of these cells. Single or multiple knockdowns of CCRK, ICK, and MAK, or inhibition of PI3K, led to de novo formation of primary cilia and suppression of cell cycle re-entry. Major strengths of the study are mechanistic insights of ciliary length regulation by CCRK identifying upstream and downstream regulators, demonstration that new cilia can not only be induced to form in a cancer cell line, but they can also affect cell cycle re-entry. Although, the role of cilia in cell cycle re-entry has been shown (refs 4 and 5), such a role in cancer cells has been unknown. Induction of cilia in a cancer line has important implications in anticancer approaches, as cancer cell proliferation can be suppressed by inducing primary cilia. In this regard, the paper shows that such approaches can be feasible and provides proof of principle that induction of cilia in a cancer cell line does suppress cell proliferation. However, several points need to be addressed before further consideration. 1) Depletion of CCRK leads to longer cilia (24 h) and higher ciliation frequency at an earlier time point (8 h). Better characterization of endogenous CCRK is needed: where is it expressed in the cell? Is it regulated during the cell cycle? Does knockdown at the mRNA reflect a similar knockdown at the protein level? Can the effect of the knockdown be rescued? This is important because the effect of a second siCCRK6 causes a questionable effect on axonemal length (Fig. S1B , please double check stats).
2) It is suggested that depletion of CCRK affects ciliary stability (page 4, last paragraph, "After serum restimulation...mammalian cells." This is not supported y the data, as the differences may not be significant. 3) Hh signaling was enhanced in longer cilia. This is an important point, but it may require further experimentation. For example, is there an effect of CCRK on a component of the Hh pathway or CCRK mediates its effects on Hh signaling through cilia? Has it been shown earlier that longer cilia enhance Hh signaling? If such an effect is known, then the existing experiments are adequate. If not, the authors may want to test whether CCRK affects Hh signaling through cilia. 4) A phosphorylation-deficient ICK mutant was used to test whether phosphorylation of ICK can account for the effects of ICK on ciliation. Based on the cited publication (ref 21), it has not been tested whether CCRK phosphorylates ICK at this residue. Therefore, it should be shown whether this is the case. In addition, results in Fig. 2B suggest that ICK(T157A) has residual activity, as transfection of control siRNA led to ~30% reduction in ciliation in cells co-transfected with ICK(T157A) compared to cells transfected with GST, which makes the interpretation of the data difficult. Also, isn't it expected that depletion of CCRK to result in higher level of ciliation in ICK(T157A)-transfected cells, if ICK(T157A) is without effect? Some clarification here is needed. 5) CCRK and ICK affect cell cycle re-entry through cilia. Isn't it expected that depletion of Kif3a promotes cell cycle re-entry, if it eliminates cilia? In this case, it appears that cells depleted Kif3a show less EdU-positive cells compared to control cells at 12 h following serum re-stimulation (Fig.  3B ). 6) The de novo generation of cilia in U251G cells upon depletion of CCRK, ICK, or both is remarkable and to my knowledge, is the first demonstration that cilia formation can be induced in a cancer cell line. Are these cilia functional, for example in terms of Hh signaling? 7) The authors may need to clarify how an increase in ciliation by only up to 7-9% in U251G cells depleted of CCRK, led to a suppression of cell cycle progression by up to 77.6%. What is the fraction of U251G cells that is normally cycling? It also appears that CCRK promotes cell cycle reentry independently of cilia (~40% reduction in EdU+ cells in cells depleted of both CCRK and Kif3a). We acknowledge the importance of using synchronised cell population considering the correlation between cell cycle and ciliogenesis. The cells used in most of our experiments in the original manuscript were serum starved and thus presumed to be arrested at G0/G1 border. In the revised manuscript we provide FACS data confirming this is indeed the case and that there is no detectable difference in the cell cycle profile of CCRK knockdown cells compared to controls (revised Fig S1B) .
R1-1a. On a general note, I was not able to find information about the number of cells analysed in every experiment. This is of course important to understand the relevance of the phenotype in NIH3t3 cells and in the glioblastoma cell line.
Information on numbers of cells analysed in each experiment was indicated in the figure legends; for more clarity we have now included cilia numbers in the actual figures where appropriate.
R1-1b. In addition, I am also not sure whether the authors performed rescue experiments to validate the specificity of CCRK knock down. I known that knock down of CCRK orthologues in other species gives similar results, but nevertheless this type of experimental control is essential in knock down experiments.
The rescue experiments using a siRNA-resistant construct expressing CCRK have been included in the revised manuscript (revised Fig 1D-E, WT) . These experiments also demonstrated that CCRK overexpression decreases ciliation and ciliary length. Furthermore, we used a kinase-deficient mutant of CCRK (also resistant to siRNA; revised Fig 1D-E , K33M) to demonstrate that the ciliary function of CCRK is dependent on its kinase activity.
R1-2. In Figure 1, the cilium size in CCRK depletion is double the control cilium size. On average length, this is much less evident (2.8 vs 2.3). Also the variation in axoneme length seems enormous both in control and depletion. Can the authors comment on this? The use of synchronised cells would probably help.
The cells in fact were synchronised by a 24 h serum starvation (revised Fig S1B) , and while there is significant variation in axoneme length in these conditions, we consider the data and methods appropriate to make the conclusion that there is a significant difference in average axoneme length. One possible reason for this comment is that in earlier reports (e.g. Ref. 4 and 5 in the revised manuscript) SEM was used instead of SD to demonstrate the accuracy of the mean, and accordingly the length data in the revised manuscript is shown with SEM (revised Fig 1B, 1E , 4C and S1C).
R1-3a. The Hg signalling evaluation suggests to the authors increased Hg signalling activity. They mention, page 5, "in cells where cilia frequency was comparable to siNT cells. I do not understand the sentence or the way the experiment was done. Are the authors certain that both cell types are at the same cell cycle phase?
The cell cycle profiles of siNT and siCCRK cells are comparable (serum-starved; see also revised Fig  S1B) . The quoted phrase suggests the referee misunderstood the original sentence (and we agree it was not clearly written): the increased Hh signalling is noted in the whole cell population and the mention about cilia frequency was only to remind that in the conditions used (48 h serum starvation) the cilia frequency is comparable in siNT and siCCRK cells. The quoted sentence has been modified in the revised manuscript: "A significant elevation of Hh pathway activity was noted in siCCRK cells by both assays (supplementary Fig S1F-G We agree it would be very interesting to dissect whether depletion of CCRK increases Hh signalling activity through increasing ciliary length. Regarding this, we compared the lengths of cilia with to without Gli3 at tips. In both siNT and siCCRK cells, Gli3 positive cilia are slightly but significantly longer than Gli3 negative cilia (in siNT: 2.42±0.07 vs 2.17±0.07, p = 0.0095; in siCCRK: 2.91±0.08 vs 2.64±0.07, p = 0.0127, shown as mean ±SEM in μ m, 114-138 cilia of each group were measured). The result in siNT cells suggests that in wild type cells, longer cilia are more efficient in mediating Hh signalling. But taken together these data also suggest that cilial translocation of Gli3 depends on other factors besides ciliary length, as the average length of Gli3-negative cilia in siCCRK cells (2.64 µm) is longer than the average length of Gli3-positive cilia in siNT cells (2.42 µm).
The existence of other factors is supported by the uncoupling of ciliary length and Hh signalling activity (or cilial accumulation of Gli3) in genetically modified conditions (Lai et al., Mol Biol Cell 22, 1104 -, 2011 Jurisch-Yaksi et al., J Cell Biol 200, 709-, 2013) . The CCRK-deficient cells may provide an interesting platform to further study this issue, but we consider the results in their somewhat premature state are better left for future studies also because they are not part of the central finding (as indicated by the editor) that CCRK promotes cancer cell proliferation by inhibiting cilia formation.
To avoid implying that our results indicate increased ciliary length leads to increased Hh signalling we have modified the sentence in the revised manuscript: "Interestingly, the percentage of cells with Gli3 at ciliary tips was significantly higher in siCCRK cells than in siNT cells (supplementary Fig S1H-I The revised manuscript contains a confirmation of the earlier results demonstrating that overexpressed CCRK is not enriched in BB or cilia (revised Fig S1E) consistent with the result in Chlamydomonas where CCRK homolog LF2 is not detected in flagellar (Ref. 11 in the revised manuscript). Our unpublished results do not show specific CCRK staining with three antibodies against CCRK (AP7119a, Agilent; HPA027379, Sigma and N-terminal CCRK antibody, Qiu et al., J Biol Chem 283, 22157-, 2008 ) using siCCRK cells as control. On a separate note we would like to point out that ICK is not localized to the BB but rather to the distal tip of cilia (Fig 2A, S2B and S2D in the revised manuscript).
R1-5. The authors show that Alanine substitution in the fusion GST-ICK-T157 does not affect its localisation, but has an effect on ciliogenesis. An alternative experiment should be performed. Can the authors phosphomimick phosphorylation in the same residue and see an effect in Control and CCRK depleted cells?
The suggested experiment has been performed and included in the revised manuscript (revised Fig.  2) . The results show that the phosphomimetic mutant of ICK inhibits ciliogenesis, and is no longer sensitive to CCRK knockdown.
R1-6a. The interpretation of the data where Kif3A is depleted is somehow confusing. The authors state that CCRK or ICK knockdown did not increase cilia length in Kif3a depleted cells. In my interpretation this result shows quite directly that the effect on cilia size is IFT dependent.
We agree with the referee and have modified the interpretation in the discussion accordingly (page 12 in the revised manuscript).
R1-6b. When measuring the % of cells with EDU incorporation, the authors state that CCRK and ICK promote cell cycle progression by inhibiting ciliogenesis. However, another interpretation is that inhibition of cell cycle progression by CCRK/ICK takes place (requires a) at a functional cilium.
We agree it is formally possible that CCRK and ICK have two different functions at cilia, i.e. to inhibit ciliogenesis and to use cilia merely as a platform to promote cell cycle progression. It is important to notice that knockdown of CCRK or ICK does not elongate the remaining cilia in shKif3a cells (Fig S3A) in conjunction with a complete rescue of the reduced EdU incorporation (Fig 3B) . Thus we stated the quoted sentence in the original manuscript. But it could be argued that the remaining cilia in shKif3a NIH3T3 cells are still structurally/functional altered (where CCRK/ICK could not enforce their effects on cell cycle re-entry anymore) or the increased fraction of 0-1 μm cilia (from about 15% in shNT to 40% in shKif3a cells) dominates the effects on EdU incorporation.
However, the observation that glioblastoma cells where cilia are restored by CCRK knockdown no longer enter S phase (revised Fig. S4A-B) together with the data demonstrating that preventing cilia restoration can rescue the defects in cell proliferation by CCRK knockdown (Fig 5 and S5) indicate that CCRK promotes cell cycle through inhibition of ciliogenesis. Therefore we consider the model that the inhibition of ciliogenesis by CCRK/ICK promotes cell cycle progression the most likely also in NIH3T3 cells.
Because the results with U251MG are after the quoted sentence, we changed the quoted part taking into account of Referee's point. In the revised manuscript, 1. the subtitle of NIH3T3 EdU part has been changed into: "CCRK and ICK promote cell cycle re-entry in a cilium-dependent manner" 2. the last sentence of this part has been changed into: "These results suggest that CCRK and ICK promote cell cycle progression by inhibiting ciliogenesis in NIH3T3 cells." Fig 3 and S3, We have now also more clearly indicated that the cells in Fig 3 and Fig S3A are synchronized using Indeed; this data is in the revised Fig 4C. 
R1-6c. In the experiment provided in

R1-7b. Also a cell cycle profile analysis done with Facs would probably help to characterise the cycling/non-cycling population in both NIH3t3 and U251 cells.
As suggested we performed FACS analyses of control and CCRK knockdown cells, and did not detect any significant changes in serum-starved conditions (revised Fig S1B and data not shown) . In addition, we have used EdU labelling allowing combined cilia staining to demonstrate that the U251MG cells with restored cilia are non-cycling (revised Fig S4A-B) .
Referee #3: R3-1a. The difference in axoneme length reported in Fig. 1B, although We agree that the difference in length is not dramatic, but it is consistent and significant in all the experiments performed. In addition, we would like to point out that a small difference in length might reflect more profound changes in ciliary function. For example, the intraflagellar transport might be severely affected, which is not revealed by examination of cilia morphology. It has been shown that in certain conditions, the ciliary trafficking of Gli and Smo is affected as well as the Hh signalling even without any detectable morphology abnormalities of cilia ( Please see our answer to the point 1b stated by Referee #1 (R1-1b above). Fig. 4 As suggested we performed FACS analyses of control and CCRK knockdown U251MG cells, and did not detect significant changes in G0/G1 in serum-starved condition (67.6±2.6% vs 70.2±5.7%) where 8% cilia restoration was observed in CCRK knockdown cells. Using shKIF3A and shIFT20 cells, we have demonstrated that the defect in cell proliferation following CCRK knockdown is significantly rescued when cilia restoration is prevented (Fig 5 and S5 ). Thus we conclude that the ciliary effect of CCRK is not secondary to changes in cell cycle but rather that CCRK promotes proliferation by inhibiting ciliogenesis. Fig. 4E and Fig.  4F .
R3-2a.
R3-2b. Secondly, the authors need to explain how such a seemingly small impact on the fraction of ciliated cells can have such a major consequence on cell proliferation, as reported in
Initially it should be pointed out that only part of CCRK cell proliferation defect (77.6% decrease in cell numbers after 8 days) is due to cilia (as shown in shKIF3A and shIFT20 cells, 39.9% decrease; Fig 5  and S5) . Thus the ciliary effect on cell proliferation is 37.7% (39.9% subtracted from 77.6%). The doubling time of U251MG cell is 24h (1 day; Ref. 28 in the revised manuscript & our observation). The EdU labelling experiments combining with cilia staining demonstrate that the U251MG cells with restored cilia (6% more in CCRK knockdown vs. control cells) are non-cycling (revised Fig. S4A-B) . Modelling U251MG proliferation (see Table below ) taking this 6% decrease into account during 8 days ("6% non-cycling") indicates a 39% decrease in cell numbers after 8 days, which is remarkably close to the observed ciliary effect (37. 
R3-3. On page 4, the authors write that the role of CCRK in ciliary length control is "... consistent with previous work in Chlamydomonas...". In fact, the LF2 mutant phenotype in Chlamydomonas is quite distinct from the slightly longer axoneme phenotype reported here upon CCRK knockdown, with flagella being typically shorter and exhibiting an altered morphology in the LF2 mutant cells. Moreover, although this is not the focus of the study, an analysis of primary cilia upon depletion of CCRK with electron-microscopy would have been an interesting addition, also to further explore potential phenotypic similarities between organisms.
The referee brings up an interesting point not discussed at length in the original manuscript. While it is true that the complete loss of LF2 (lf2-6) leads to short flagella, the gene was identified based on the phenotype of five other alleles (partial loss of function) leading to long flagella (LF = long flagella) (Ref.
11 in the revised manuscript). As with many cilia regulators it is thus clear that LF2 regulates flagella length in a complex and variable manner. The CCRK knockdown in NIH3T3 cells represents a partial loss of function, and it will be very interesting to see the potential ciliary phenotype of a mammalian CCRK null allele. Before this we consider it premature to extend the discussion on the similarities of the phenotypes also considering the significant differences in the LF2 and CCRK e.g. in respect to the length regulatory complex (LRC). But we have modified the relevant part in the revised manuscript into:
"The role of CCRK in ciliary length control is consistent with previous observations in Chlamydomonas, where a CCRK homolog (LF2) is involved in flagella length regulation [11]. The elongated primary cilia in CCRK-depleted NIH3T3 cells were not detectably curled as reported for motile cilia in CCRK-deficient zebrafish kidney tubules [12], suggesting that CCRK regulation of cilia formation is context and possibly dose dependent as for LF2 [11]."
R3-4. In several places (e.g. Fig. 1B, Fig. 3B, Fig. S2D ), the authors show the data from only one representative experiment, even though they have conducted several of them. The entire data set should be shown, which is especially important considering that the changes reported in some of these cases are rather small (e.g. in Fig. 1B for instance) . Regarding to the comment of small changes in length, we agree that the increase in length by CCRK knockdown is not dramatic, but it is consistent and significant in all the experiments performed and repeatedly shown in the revised manuscript (Fig 1B, 1E, S1C, S3A) . Besides, the rescue experiments demonstrate a gain of function of CCRK and a fully rescue of the effect on length by siCCRK. Thus we feel unnecessary to show the entire data set in the revised manuscript.
There is no Fig. S2D in the original manuscript. Fig. 1B ) to analyzing the fraction of cells with cilia (as in Fig. 2 ). The two are not interchangeable and correspond to distinct cell biological processes that should be treated separately.
R3-5. The authors switch from analyzing the length of primary cilia (as in
We agree that ciliation and ciliary length can correspond to distinct processes. In this study we have analysed both in all experiments except in Fig 2, where the inhibition of ciliation by ICK is so prominent and by analysing it alone we consider sufficient to demonstrate the link between CCRK and ICK. Fig. S3 .
R3-6. Statistical analysis should be performed for the data reported in
The statistical significances calculated from three separated experiments are indicated in the revised Fig S3 as suggested. Fig. 1C 
R3-7. On page 4, the authors conclude from the data reported in
that "...CCRK knockdown increases cilia stability" and that "...CCRK is a negative regulator of ciliogenesis". These appear as overstatements in the light of the available data. Are the differences between siNT and siCCRK upon serum restimulation and reported in Fig. 1C statistically significant? This should be clarified.
The statistical significances calculated from three separated experiments are indicated in the revised Fig 1C and demonstrate a clear difference in ciliation by CCRK knockdown after serum restimulation.
R3-8. The authors report the intriguing observation that there is an elevation of Hh pathway activity in cells depleted of CCRK, and imply that this correlates with the presence of longer cilia. This interesting suggestion could be addressed experimentally, for instance by testing whether the extent of the presence of Gli3 at ciliary tips correlates with ciliary length amongst cells depleted of CCRK.
Please see our answer to the point 3b stated by Referee #1 (R1-3b above).
R3-9. At the end of page 5, the authors introduce MAK as the most logical CCRK substrate to investigate, but then chose to study ICK instead without ever coming back to MAK. This is somewhat unsettling.
The reason for not studying MAK in NIH3T3 cells was the lack of its expression in this cell type ( Fig  S2A) . In glioblastoma cells MAK is expressed and was included in the studies (Fig 4C in the original manuscript; Fig 4E in the revised manuscript) .
R3-10. The fact that CCRK knockdown does not alter ciliary frequency in GST-ICK-T157A expressing cells (Fig. 2B) leads the authors to conclude that ICK mediates the inhibitory function of CCRK. To strengthen this claim, the authors should consider testing whether a T157D/E mutant behaves like GST-ICK.
Please see our answer to the point 5 stated by Referee #1 (R1-5 above). Please see our answer to the point 6b stated by Referee #1 (R1-6b above).
R3-
R3-12. The findings reported in Fig. S4B implicating PI3K as a potential regulator of CCRK are of interest, but appear insufficiently developed for the time being to warrant inclusion in this manuscript, especially since the contribution of PI3K is only partial.
We agree that the contribution of CCRK to PI3K's cilia inhibition in glioblastoma is partial. However, we (and Referee #4) consider the link between activated PI3K and CCRK overexpression in glioblastoma cells is relevant. Accordingly, we have made significant changes in the revised manuscript including text changes in abstract and result parts, deletion of the lower panels in the original Fig S5A and Fig S4D-F) .
R3-13. In the discussion, the authors claim to have identified a "novel mechanism of ciliogenesis inhibition" (page 10). This claim is no warranted because there is little mechanistic insight in this study about how CCRK/ICK negatively regulate this process, and also because the requirement of these proteins in ciliogenesis is far from "novel".
While we consider that linking CCRK and ICK/MAK in negative regulation of ciliogenesis and implicating them in IFT regulation does provide some mechanistic insight, we now agree that this is not a full mechanism as of yet, and therefore we have modified this sentence in the revised manuscript at the beginning of the discussion: "Overall the study demonstrates that CCRK inhibits ciliogenesis through ICK and MAK and further that this mechanism is used to increase the proliferative capacity of glioblastoma cells." Fig. 1D (which does not exist) instead of Fig. 2A when mentioning the localization of ICK.
R3-14. On page 11, the authors refer to
We apologize for this shortcoming; this is corrected in revised manuscript.
R3-15. In the Methods section, the authors should indicate the source of their cell lines.
Included in revised manuscript (ATCC).
R3-16. Some references are incomplete (e.g. # 15 or 36)
We thank the referee for pointing out these mistakes and have corrected them in the revised manuscript.
R3-17. The wording in the Supplementary Methods section could use some polishing.
This part has been rewritten. Fig 1D-E) .
Referee #4:
R4-1. Depletion of CCRK leads to longer cilia (24 h) and higher ciliation frequency at an earlier time point (8 h). Better characterization of endogenous CCRK is needed
R4-2. It is suggested that depletion of CCRK affects ciliary stability (page 4, last paragraph, "After serum restimulation...mammalian cells." This is not supported by the data, as the differences may not be significant.
In the revised manuscript we have incorporated data from three separate experiments demonstrating a significant difference in ciliary stability (revised Fig 1C) .
R4-3. Hh signaling was enhanced in longer cilia. This is an important point, but it may require further experimentation. For example, is there an effect of CCRK on a component of the Hh pathway or CCRK mediates its effects on Hh signaling through cilia? Has it been shown earlier that longer cilia enhance Hh signaling? If such an effect is known, then the existing experiments are adequate. If not, the authors may want to test whether CCRK affects Hh signaling through cilia.
First we would like to point out that we do not consider that the data in the original or revised manuscript demonstrate that Hh signalling is enhanced in longer cilia: while we do note both increased Hh signalling and longer cilia, the causality is not trivial to establish considering the complex relationship of cilia structure and Hh signalling (e.g. Lai et al., Mol Biol Cell 22, 1104 -, 2011 . We agree with the referee that demonstrating that Hh signalling is enhanced in longer cilia would be interesting, and therefore performed new analyses to explore the possibility (see our answer to Referee 1, R1-3b above) but consider the results premature.
To avoid implying that our results indicate increased ciliary length leads to increased Hh signalling we have modified the sentence in the revised manuscript: "Interestingly, the percentage of cells with Gli3 at ciliary tips was significantly higher in siCCRK cells than in siNT cells (supplementary Fig S1H-I (Fig. 5, lane 3) . Regardless of the activity of ICK-T157A, depletion of CCRK would not be expected to result in higher level of ciliation, as CCRK can not phosphorylates T157A (or T157E): the data indicated CCRK can only regulate wild-type ICK through T157 site.
R4-5. CCRK and ICK affect cell cycle re-entry through cilia. Isn't it expected that depletion of Kif3a promotes cell cycle re-entry, if it eliminates cilia? In this case, it appears that cells depleted Kif3a show less EdU-positive cells compared to control cells at 12 h following serum re-stimulation (Fig. 3B).
We thank the referee for pointing out this apparent contradiction. The apparently inhibitory effect on cell proliferation by Kif3a depletion (in contrast to the opposite effect by depletion of other IFT components, e.g. Ift172) has been reported and thoroughly discussed in Ref. 24 in revised manuscript.
To rule out the possibility that the rescue of decreased EdU incorporation in CCRK/ICK knockdown cells ( Fig 3B in the original manuscript) is due to some cilium-independent function of Kif3a, we have performed the EdU experiments in shIft172 cells. These cells show increased EdU incorporation and no significant changes following CCRK or ICK knockdown (Revised Fig S3C) . Thus the new results further strengthen the conclusion that CCRK/ICK affect cell cycle re-entry through cilia.
R4-6. The de novo generation of cilia in U251G cells upon depletion of CCRK, ICK, or both is remarkable and to my knowledge, is the first demonstration that cilia formation can be induced in a cancer cell line. Are these cilia functional, for example in terms of Hh signaling?
Indeed the cilia appear functional based on IFT88 staining (revised Fig. 4D ) and also based on the observation that the ciliated cells do not enter S phase (revised Fig S4A-B) .
R4-7. The authors may need to clarify how an increase in ciliation by only up to 7-9% in U251G cells depleted of CCRK, led to a suppression of cell cycle progression by up to 77.6%. What is the fraction of U251G cells that is normally cycling? It also appears that CCRK promotes cell cycle re-entry independently of cilia (~40% reduction in EdU+ cells in cells depleted of both CCRK and Kif3a).
For the first point please see our answer to the point 2b stated by Referee #3 (R3-2b above). We agree with the Referee that CCRK can promote cell proliferation also independently of cilia as indicated in original and revised manuscripts. Thank you for the submission of your revised manuscript. We have now received the enclosed reports from 2 referees. While the third referee has not yet returned his/her report, I am sending you the 2 reports we have now so that you can start to address the remaining concerns. The referee suggestions need to be addressed before we can proceed with the acceptance of your manuscript.
I agree with referee 3 that the combined results of all experiments performed should be shown in Fig  1B and E , that the title and text of the manuscript needs to be adjusted in order to more accurately reflect the findings, and that the FACS data of U251MG cells depleted for CCRK should be included. However, if you prefer, I think the PI3K inhibitor experiment can stay in the main figure, and figures 4 and 5 can stay separate.
I also noticed that the information on the statistical test used to calculate the p-value in figure 5B is missing in the figure legend.
Finally, I would like to include some minor changes to the abstract, as follows.
Loss of primary cilia is frequently observed in tumour cells including glioblastoma cells and proposed to benefit tumour growth, but a causal link has not been established. Here we show that CCRK (Cell Cycle Related Kinase) and its substrate ICK (Intestinal Cell Kinase) inhibit ciliogenesis. Depletion of CCRK leads to accumulation of ICK at ciliary tips, altered ciliary transport, and inhibition of cell cycle re-entry in NIH3T3 fibroblasts. In glioblastoma cells with deregulated high levels of CCRK, its depletion restores cilia through ICK and an ICK related kinase MAK, thereby inhibiting glioblastoma cell proliferation. These results suggest that inhibition of ciliogenesis may be a mechanism used by cancer cells to provide a growth advantage.
Please let me know if you agree with these changes.
I look forward to seeing a new revised version of your manuscript as soon as possible. Given that it is EMBO reports policy that manuscript must be accepted at the latest 6 months after the first decision was made, we need to receive the revised manuscript latest on the 10th of June. Please let me know if you have any questions or comments.
REFEREE REPORTS:
Referee #3:
Review of revised manuscript by Yang and coworkers (EMBOR-2012-36935V2) The authors conducted several experiments and altered the text to address most of the concerns raised by the three reviewers of the original submission. As a result, the manuscript is strengthened, such that publication in EMBO Reports could be envisaged after the authors address the remaining issues listed below.
A) I remain of the opinion (see point 4 in my initial review) that the authors should show the combined results of all the experiments they conducted, and not only a representative experiment, in Fig. 1B and in Fig. 1E . Just to reiterate, this appears especially important given the very small difference between control cells and upon CCRK depletion.
B) As indicated already in my initial review (point 11), and despite the response of the authors to reviewer 1 (R1-6b) on this point, I still think that while the results do demonstrate that the effect of depleting CCRK on cell cycle progression requires the presence of cilia, they do not establish that the kinase promotes cell cycle progression by inhibiting ciliogenesis. The wording should be adjusted to reflect this important distinction (for instance last sentence on p. 8).
C) It is unclear why the authors assessed the extent of Hh pathway activation 48 hours after serum starvation ( Fig. S1F-G) , whereas the consequence of CCRK depletion on cilia was scored 24 hours after serum starvation (Fig. 1A-C) . The same conditions should be utilized or else the authors should discuss why different experimental conditions were chosen.
D) The authors conclude (p. 7) that the ciliary function of CCRK is mediated through ICK-T157 phosphorylation. However, their data indicates that this is only partially the case, since GST-ICK does not rescue the fraction of cells with cilia to the level observed in control cells. The wording should be correctly accordingly.
E) The authors should show the FACS data of U251MG cells upon CCRK depletion that is currently only mentioned as data not shown, because this is critical for readers to assess the conclusions drawn from the experiment reported in Fig. 5 .
F) Based on their EdU experiments, the authors conclude that cells with restored cilia do not enter S phase. Have the authors assessed whether there is a permanent block in cell cycle entry or instead merely a delay in entering S phase? This distinction has a major incidence on the back-of-theenvelope calculations that lead the author to conclude that the observed small impact on the faction of ciliated cells can fully explain the differences in cell proliferation. Referee #4:
The paper by Yang et al has been substantially improved. The conclusions are supported by the data and the findings are novel. Overall, this is a complete study that would advance our understanding of the role of cilia in cancer. However, I still have some concerns that were not addressed in the revised version.
1) The main point of paper is on the role of CCRK in ciliogenesis but there is not a single experiment showing endogenous CCRK protein levels, either in cells where CCRK was downregulated or in native cells. I agree with the authors that rescue experiments provide support for specificity of the experiments, but they also have their own caveats, ie, massive overexpression effects, etc.
2) Accumulation of Gli3 in the tips of newly formed cilia in U251MG glioblastoma cells after CCRK knockdown should be shown to provide an independent demonstration that these cilia are functional.
3) The assumption that 6% of U251MG ciliated are not proliferating and thus, excluded from the analysis is not a valid one. These cells would not stop proliferating, as ciliated cells do proliferate, but at a slower rate compared to non-ciliated cells. In a time period of 8 days, I would expect that the population of ciliated U251MG cells would contribute at some degree to the overall cell population. Fig. S1F-G) , whereas the consequence of CCRK depletion on cilia was scored 24 hours after serum starvation (Fig. 1A-C) . The same conditions should be utilized or else the authors should discuss why different experimental conditions were chosen.
The reason for choosing to use 48 hours starvation for the Gli-Luc experiment was based on a previous publication (Supplementary Reference 1). The referee however helped us to note a small mistake and an important point we had not indicated: i) while the Gli-Luc experiments were done after a 48 h serum starvation, the mRNA measurements were done after a 40 h starvation as indicated in the supplementary figure legend, but mistakenly referred to as 48 h in the main text (fixed in the 2 nd revised version); ii) and more importantly, the Gli3 staining experiment also showing an increase in Hh pathway activity was done in the same condition (24 h serum starvation) as the cilia measurements after CCRK knockdown. We have modified the main text of the manuscript accordingly (and also fixed an error in the Supplemental Figure legend As suggested, the FACS data is shown in the 2 nd revised Fig S5B. 
R3-F. Based on their EdU experiments, the authors conclude that cells with restored cilia do not enter S phase. Have the authors assessed whether there is a permanent block in cell cycle entry or instead merely a delay in entering S phase? This distinction has a major incidence on the back-of-theenvelope calculations that lead the author to conclude that the observed small impact on the faction of ciliated cells can fully explain the differences in cell proliferation.
In the previous version of the manuscript (V2) we provided a possible explanation (not a conclusion) for how a 6% increase in ciliation could lead to the noticeable reduction in cell numbers as observed in Fig 5. This was based on a hypothesis that ciliated cells would not proliferate, and supported by a dramatic reduction in EdU incorporation in ciliated cells noted during a 12 h EdU pulse where a single cell from 100 ciliated cells counted from three experiments is EdU positive (Fig S4A-B) . We hope the rewording in the revised manuscript is clearer on this: "Interestingly, cells with restored cilia are severely compromised in their ability to incorporate EdU indicating a block or severe delay in cell cycle progression (supplementary Fig S4A- Fig S4A-B) ." (page 11)
R3-G. I remain of the opinion (see point 12 of the original review) that the results with the PI3K inhibitors do not belong to this manuscript.
Here we have followed the editor's recommendation.
R3-H. Figures 4 and 5 could be merged.
Here we have followed the editor's recommendation. We agree with the referee that obtaining reagents to enable analysis of endogenous CCRK will be a valuable addition to the studies performed in the manuscript using reagents currently available as detailed in our previous correspondence.
R4-2. Accumulation of Gli3 in the tips of newly formed cilia in U251MG glioblastoma cells after CCRK knockdown should be shown to provide an independent demonstration that these cilia are functional.
We agree with the referee that it is potentially interesting to study whether Gli3 would accumulate in the tips of restore cilia following CCRK knockdown. However the concern of whether the cilia are functional or not we consider to be better addressed by the experiment (IFT88 staining) we already added as a response to the same concern of the referee in the previous round (R4-6 in first round of modification) instead of Gli3 staining due to the complex relationship of primary cilia, Hh signalling pathway and tumorigenesis (Ref 25, 26 in the manuscript) and uncertainty of whether Hh signalling is active in human glioblastoma cells (including U251MG cells used in our study; Katayam M et al., J Neurooncol. 2002 Sep; 59(2): 107-) . Considering this and that this request was made on top of a previous request we addressed in the first round we have not performed the experiment in the interest of time. Please see our answer to the point F stated by Referee #3 (R3-F above).
R4-
cell cycle profiles of these cells (supplementary Fig S5B) , indicating these cells can be used to identify the cilium-dependent functions of CCRK. SUGGESTED MODIFICATION: Restoration of cilia was readily detected following CCRK knockdown in shNT cells but not in shKIF3A cells (supplementary Fig S5A) . Concomitantly a small albeit non-significant increase in the total G1 population was noted in CCRK-depleted cells (supplementary Fig S5B) ; this increase was not noted in shKIF3A cells. These results indicated the shNT and shKIF3a cells can be used to identify the cilium-dependent functions of CCRK.
Please let me know if these changes are satisfactory I am very pleased to accept your manuscript for publication in the next available issue of EMBO reports. Thank you for your contribution to our journal. As indicated in your last email, we will change the title and the one sentence you point out for you.
As part of the EMBO publication's Transparent Editorial Process, EMBO reports publishes online a Review Process File to accompany accepted manuscripts. As you are aware, this File will be published in conjunction with your paper and will include the referee reports, your point-by-point response and all pertinent correspondence relating to the manuscript.
If you do NOT want this File to be published, please inform the editorial office within 2 days, if you have not done so already, otherwise the File will be published by default [contact: emboreports@embo.org]. If you do opt out, the Review Process File link will point to the following statement: "No Review Process File is available with this article, as the authors have chosen not to make the review process public in this case."
Finally, we provide a short summary of published papers on our website to emphasize the major findings in the paper and their implications/applications for the non-specialist reader. To help us prepare this short, non-specialist text, we would be grateful if you could provide a simple 1-2 sentence summary of your article in reply to this email.
Thank you again for your contribution to EMBO reports and congratulations on a successful publication. Please consider us again in the future for your most exciting work.
